Because SPRAVATO® is a nasal (nose) spray the medication is absorbed very quickly. This rapid onset provides improvement of depression symptoms in hours to days.

At Week 4 in a 2019 clinical study, 52.5% of patients receiving SPRAVATO® + oral antidepressant (AD) achieved remission vs 31.0% with placebo + oral AD.